Aristeia Capital’s EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant EQHA.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-565,200
Closed -$5.69M 908
2021
Q4
$5.69M Hold
565,200
0.1% 246
2021
Q3
$5.65M Hold
565,200
0.11% 235
2021
Q2
$5.63M Sell
565,200
-34,800
-6% -$348K 0.11% 231
2021
Q1
$5.95M Buy
+600,000
New +$6.09M 0.12% 235

Other funds holding EQHA.U

Aristeia Capital's EQHA.U Position: Q1 2022 in Review

Aristeia Capital sold out of EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant (EQHA.U) in Q1 2022, closing a stake of 565,200 shares — an estimated $5.69M sold.

Aristeia Capital first reported a position in EQHA.U in Q1 2021 and held it in 4 quarters. The position peaked at $5.95M in Q1 2021. 17 funds tracked by Wall St. Rank hold EQHA.U as of Q1 2022.

  • Aristeia Capital reported no remaining EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant position as of Q1 2022 after selling out during the quarter.
  • Aristeia Capital sold 565,200 EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant shares in Q1 2022, an estimated $5.69M.
  • Aristeia Capital first reported a position in EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant in Q1 2021 and held it in 4 quarters.
  • Aristeia Capital's EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant position peaked at $5.95M in Q1 2021.
  • 17 funds tracked by Wall St. Rank held EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant as of Q1 2022.

Based on Aristeia Capital's 13F filing for Q1 2022, filed 16 May 2022.